Opus Genetics Inc（IRD）價格預測IRDOpus Genetics Inc

Alphio's IRD stock price prediction model matches the current Opus Genetics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.86 (+1.03%). The 1-week path is $4.01 (+5.05%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Opus Genetics Inc is a good buy right now due to its recent FDA approval for a new eye drop treatment, which is expected to drive future revenue growth. The current price is $3.84, and analysts have set a price target as high as $20, suggesting a potential upside of over 420%. Additionally, the stock has shown a year-to-date change of +81.13%, indicating strong performance despite recent volatility. However, the RSI is currently at 17.549, indicating that the stock is oversold and may rebound. The main risk is the company's significant net losses, with a net income of -65.5 million in Q1 2026, which could impact investor confidence.

Opus Genetics Inc (IRD) last closed at $3.82, losing -7.17%. These facts feed the 1-day and 1-week IRD price prediction above.